Johnson & Johnson COVID-19 vaccine has ‘favorable safety profile,’ FDA staff finds

The Food and Drug Administration posted documents Wednesday finding a single-dose vaccine developed by Johnson & Johnson had “favorable safety profile with no specific concerns identified that would preclude issuance of an EUA.”